On Thursday, September 3rd, MaRS announced and welcomed their upcoming health and life science anchor tenants to MaRS West Tower…and U of T was confirmed as having acquired a 20% undivided interest in the MaRS Phase 2 Investment Trust – a share of the West Tower.

This was the first in a series of tenant announcements planned for the fall, and you can read Vice-President Scott Mabury’s remarks here.